Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Receivables: 2014-2024

Historic Change in Receivables for CorMedix (CRMD) over the last 10 years, with Dec 2024 value amounting to $51.8 million.

  • CorMedix's Change in Receivables rose 407.94% to $87.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.9 million, marking a year-over-year increase of 557.31%. This contributed to the annual value of $51.8 million for FY2024, which is N/A change from last year.
  • CorMedix's Change in Receivables amounted to $51.8 million in FY2024, which was up 122,992.49% from -$42,143 recorded in FY2022.
  • In the past 5 years, CorMedix's Change in Receivables registered a high of $51.8 million during FY2024, and its lowest value of -$42,143 during FY2022.
  • Over the past 2 years, CorMedix's median Change in Receivables value was $25.9 million (recorded in 2022), while the average stood at $25.9 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first spiked by 1,327.00% in 2021, then crashed by 195.61% in 2022.
  • Over the past 4 years, CorMedix's Change in Receivables (Yearly) stood at $3,089 in 2020, then skyrocketed by 1,327.00% to $44,080 in 2021, then plummeted by 195.61% to -$42,143 in 2022, then reached $51.8 million in 2024.